These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16449092)

  • 1. Atypical antipsychotic medication and substance use-related outcomes in the treatment of schizophrenia.
    Petrakis IL; Leslie D; Finney JW; Rosenheck R
    Am J Addict; 2006; 15(1):44-9. PubMed ID: 16449092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Addiction Severity Index medical and psychiatric composite scores measure similar domains as the SF-36 in substance-dependent veterans: concurrent and discriminant validity.
    Calsyn DA; Saxon AJ; Bush KR; Howell DN; Baer JS; Sloan KL; Malte CA; Kivlahan DR
    Drug Alcohol Depend; 2004 Nov; 76(2):165-71. PubMed ID: 15488340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of system-wide outcomes monitoring data to compare the effectiveness of atypical neuroleptic medications.
    Sernyak MJ; Leslie D; Rosenheck R
    Am J Psychiatry; 2003 Feb; 160(2):310-5. PubMed ID: 12562578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: changes in psychiatric symptoms and substance use.
    Margolese HC; Carlos Negrete J; Tempier R; Gill K
    Schizophr Res; 2006 Mar; 83(1):65-75. PubMed ID: 16460917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differing effects of antipsychotic medications on substance abuse treatment patients with co-occurring psychotic and substance abuse disorders.
    Stuyt EB; Sajbel TA; Allen MH
    Am J Addict; 2006; 15(2):166-73. PubMed ID: 16595355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive behavior therapy for schizophrenia in patients with mild to moderate substance misuse problems.
    Naeem F; Kingdon D; Turkington D
    Cogn Behav Ther; 2005; 34(4):207-15. PubMed ID: 16498749
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term course of substance use disorders among patients with severe mental illness.
    Bartels SJ; Drake RE; Wallach MA
    Psychiatr Serv; 1995 Mar; 46(3):248-51. PubMed ID: 7796211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life in schizophrenia on conventional versus atypical antipsychotic medication: a comparative cross-sectional study.
    Mortimer AM; Al-Agib AO
    Int J Soc Psychiatry; 2007 Mar; 53(2):99-107. PubMed ID: 17472084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders.
    San L; Arranz B; Martinez-Raga J
    Eur Addict Res; 2007; 13(4):230-43. PubMed ID: 17851245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition to low intensity case management in a VA Assertive Community Treatment model program.
    Rosenheck RA; Neale MS; Mohamed S
    Psychiatr Rehabil J; 2010; 33(4):288-96. PubMed ID: 20374987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent validity of clinicians' ratings of substance abuse among psychiatric outpatients.
    Carey KB; Cocco KM; Simons JS
    Psychiatr Serv; 1996 Aug; 47(8):842-7. PubMed ID: 8837156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of patients with substance abuse diagnoses on a general psychiatry unit in a VA Medical Center.
    Lambert MT; Griffith JM; Hendrickse W
    Psychiatr Serv; 1996 Oct; 47(10):1104-7. PubMed ID: 8890339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication noncompliance and substance abuse among patients with schizophrenia.
    Owen RR; Fischer EP; Booth BM; Cuffel BJ
    Psychiatr Serv; 1996 Aug; 47(8):853-8. PubMed ID: 8837158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].
    Wobrock T; D'Amelio R; Falkai P
    Nervenarzt; 2008 Jan; 79(1):17-8, 20-2, 24-6 passim. PubMed ID: 17619840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems in the application of the Addiction Severity Index (ASI) in rural substance abuse services.
    Wertz JS; Cleaveland BL; Stephens RS
    J Subst Abuse; 1995; 7(2):175-88. PubMed ID: 7580228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocaine use by schizophrenic outpatients who receive depot neuroleptic medication.
    Stone AM; Greenstein RA; Gamble G; McLellan AT
    Hosp Community Psychiatry; 1993 Feb; 44(2):176-7. PubMed ID: 8432504
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders.
    Brunette MF; Drake RE; Xie H; McHugo GJ; Green AI
    Schizophr Bull; 2006 Oct; 32(4):637-43. PubMed ID: 16782758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.